| Dr Jay B Jani, MD | |
|
2660 Sw 3rd St, Topeka, KS 66606-2442 | |
| (785) 354-9591 | |
| (785) 368-0739 |
| Full Name | Dr Jay B Jani |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 22 Years |
| Location | 2660 Sw 3rd St, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982922936 | NPI | - | NPPES |
| 201083600A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 04-36625 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Interim Healthcare Of Topeka | Topeka, KS | Home health agency |
| Stormont Vail Hospital | Topeka, KS | Hospital |
| University Of Kansas Health System - St Francis Campus | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
A new study published in the journal Environmental Science & Technology Letters reports that particulate matter smaller than a single micron in diameter, called PM1, is strongly linked to the occurrence of cardiovascular disease (CVD). This is thought to be due to its higher surface area to volume ratio.
Exelixis, Inc. today reported updated interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial.
The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.
Glioblastoma multiforme, a cancer of the brain also known as "octopus tumors" because of the manner in which the cancer cells extend their tendrils into surrounding tissue, is virtually inoperable, resistant to therapies, and always fatal, usually within 15 months of onset.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are introducing what the 2015 Nobel Prize Laureate Summit on Biomedical Science (NPLS) organizers published as, "game changing" and "breakthrough" early cancer detection technology research results at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29 – June 2, 2015.
› Verified 2 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
A new study published in the journal Environmental Science & Technology Letters reports that particulate matter smaller than a single micron in diameter, called PM1, is strongly linked to the occurrence of cardiovascular disease (CVD). This is thought to be due to its higher surface area to volume ratio.
Exelixis, Inc. today reported updated interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial.
The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.
Glioblastoma multiforme, a cancer of the brain also known as "octopus tumors" because of the manner in which the cancer cells extend their tendrils into surrounding tissue, is virtually inoperable, resistant to therapies, and always fatal, usually within 15 months of onset.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are introducing what the 2015 Nobel Prize Laureate Summit on Biomedical Science (NPLS) organizers published as, "game changing" and "breakthrough" early cancer detection technology research results at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29 – June 2, 2015.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jay B Jani, MD 2660 Sw 3rd St, Topeka, KS 66606-2442 Ph: (785) 354-9591 | Dr Jay B Jani, MD 2660 Sw 3rd St, Topeka, KS 66606-2442 Ph: (785) 354-9591 |
News Archive
A new study published in the journal Environmental Science & Technology Letters reports that particulate matter smaller than a single micron in diameter, called PM1, is strongly linked to the occurrence of cardiovascular disease (CVD). This is thought to be due to its higher surface area to volume ratio.
Exelixis, Inc. today reported updated interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial.
The national study will look at the best clinical practice for treating pregnant women with schizophrenia and other psychosis by setting up an Australian wide database of pregnant women with schizophrenia and related disorders. The study will follow the woman and her baby during pregnancy up to the first year of the baby's life.
Glioblastoma multiforme, a cancer of the brain also known as "octopus tumors" because of the manner in which the cancer cells extend their tendrils into surrounding tissue, is virtually inoperable, resistant to therapies, and always fatal, usually within 15 months of onset.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are introducing what the 2015 Nobel Prize Laureate Summit on Biomedical Science (NPLS) organizers published as, "game changing" and "breakthrough" early cancer detection technology research results at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29 – June 2, 2015.
› Verified 2 days ago
Eric E. Hansen, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2419 Sw Pepperwood Rd, Topeka, KS 66614 Phone: 785-231-7173 | |
Cassandra J Steinlage, PT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 785-228-1700 Fax: 785-273-0716 | |
Dr. Kay A Kile, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw Gage Blvd, Mail Stop T-117, Topeka, KS 66622 Phone: 785-350-3111 Fax: 785-350-4458 | |
Dr. Sushmita Veloor, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 634 Sw Mulvane St, Suite 401, Topeka, KS 66606 Phone: 785-357-6300 Fax: 785-357-6324 | |
Bailey Renfro, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2400 Sw Urish Rd, Topeka, KS 66614 Phone: 785-273-5001 | |
Dr. Susan Jean Englehart, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1504 Sw 8th Ave, Dr. Golding And Assoc, Kansas Rehab Hosp, Topeka, KS 66606 Phone: 785-232-8566 | |
Madonna A Mergenmeier, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 785-228-1700 Fax: 785-231-5996 |